Transdermal Preferred We prioritize transdermal estradiol delivery for its superior safety profile regarding clotting and cardiovascular risk
Weight Regain Timeline and Metabolic Rebound Research published through 2025 indicates that patients who discontinue GLP-1 without lifestyle modification regain 2550% of lost weight within 12 months, with some regaining most or all weight within 1824 months
While some people report headaches as a side effect of tirzepatide, a growing body of research suggests that GLP-1 receptor agonists, the very class of drugs tirzepatide belongs to, might actually prevent migraines
This documentation can come from the patient's own records, prior provider notes, or attestation from the prescriber based on patient history
Now, I do think that people can be misinformed in that, what you mentioned, a research-grade peptide is not meant for human consumption, and I think we do, as my legal expert told me, have a false sense of security when we see that research-grade label